Govt panel recommends nod for phase 2/3 trials of Covovax on kids

An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covid vaccine Covovax on children......

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. IMAGE: Kindly......

India gets 3rd vaccine as DCGI approves Sputnik V

India's drug regulator has granted permission for the restricted emergency use of Russian COVID-19 vaccine 'Sputnik V' with certain conditions, paving the way for a third vaccine to be available in......

Russia's Sputnik-V vaccine gets nod for use in India

An expert panel of India's central drug authority has recommended granting approval to Russian COVID-19 vaccine Sputnik V for emergency use in the country with certain conditions, sources said.......

Chidambaram's Budget speech

Speech of P. Chidambaram Minister of Finance PART A Mr. Speaker, Sir, I rise to present the Budget for the year 2005-06. 2. Last year, while presenting the Budget, I had suggested that the vote in......